Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of AURO LAB.. For more details, see the AURO LAB. quarterly results and AURO LAB. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.9 |
No. of shares | m | 6.23 |
1 Week | % | 6.6 |
1 Month | % | 33.2 |
1 Year | % | 203.2 |
52 week H/L | Rs | 204.8/63.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
AURO LAB. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 105 | 75 | 128 | 195 | 116 | |
Low | Rs | 50 | 23 | 28 | 79 | 53 | |
Sales per share (Unadj.) | Rs | 75.2 | 70.3 | 87.1 | 81.6 | 84.9 | |
Earnings per share (Unadj.) | Rs | 7.1 | 6.5 | 11.5 | 4.6 | 3.9 | |
Diluted earnings per share | Rs | 7.1 | 6.5 | 11.5 | 4.6 | 3.9 | |
Cash flow per share (Unadj.) | Rs | 8.7 | 8.2 | 13.2 | 6.2 | 5.6 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 27.9 | 34.5 | 45.9 | 50.6 | 54.9 | |
Adj. book value per share | Rs | 27.9 | 34.5 | 45.9 | 50.6 | 54.9 | |
Shares outstanding (eoy) | m | 6.23 | 6.23 | 6.23 | 6.23 | 6.23 | |
Price / Sales ratio | x | 1.0 | 0.7 | 0.9 | 1.7 | 1.0 | |
Avg P/E ratio | x | 11.0 | 7.5 | 6.8 | 30.0 | 21.5 | |
P/CF ratio (eoy) | x | 8.9 | 6.0 | 5.9 | 22.1 | 14.9 | |
Price / Book Value ratio | x | 2.8 | 1.4 | 1.7 | 2.7 | 1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 483 | 305 | 488 | 852 | 525 | |
Total wages/salary | Rs m | 29 | 35 | 36 | 37 | 38 |
AURO LAB. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 468 | 438 | 543 | 509 | 529 | |
Other income | Rs m | 10 | 10 | 8 | 11 | 9 | |
Total revenues | Rs m | 478 | 448 | 550 | 520 | 538 | |
Gross profit | Rs m | 70 | 63 | 112 | 46 | 44 | |
Depreciation | Rs m | 10 | 10 | 10 | 10 | 11 | |
Interest | Rs m | 9 | 6 | 5 | 8 | 8 | |
Profit before tax | Rs m | 61 | 56 | 105 | 39 | 34 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 17 | 16 | 33 | 10 | 10 | |
Profit after tax | Rs m | 44 | 41 | 72 | 28 | 24 | |
Gross profit margin | % | 14.9 | 14.3 | 20.7 | 9.1 | 8.3 | |
Effective tax rate | % | 27.5 | 28.1 | 31.7 | 26.6 | 29.1 | |
Net profit margin | % | 9.4 | 9.3 | 13.2 | 5.6 | 4.6 |
AURO LAB. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 187 | 179 | 280 | 373 | 354 | |
Current liabilities | Rs m | 100 | 61 | 92 | 201 | 181 | |
Net working cap to sales | % | 18.6 | 27.0 | 34.5 | 33.8 | 32.6 | |
Current ratio | x | 1.9 | 2.9 | 3.0 | 1.9 | 2.0 | |
Inventory Days | Days | 0 | 0 | 2 | 2 | 2 | |
Debtors Days | Days | 66,289,850 | 48,175,207 | 49,106,457 | 97,685 | 85,599 | |
Net fixed assets | Rs m | 148 | 144 | 139 | 176 | 206 | |
Share capital | Rs m | 62 | 62 | 62 | 62 | 62 | |
"Free" reserves | Rs m | 112 | 153 | 224 | 253 | 280 | |
Net worth | Rs m | 174 | 215 | 286 | 315 | 342 | |
Long term debt | Rs m | 46 | 32 | 24 | 17 | 20 | |
Total assets | Rs m | 335 | 323 | 419 | 550 | 560 | |
Interest coverage | x | 7.9 | 10.8 | 23.9 | 5.7 | 5.2 | |
Debt to equity ratio | x | 0.3 | 0.1 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 1.4 | 1.4 | 1.3 | 0.9 | 0.9 | |
Return on assets | % | 15.8 | 14.3 | 18.2 | 6.7 | 5.8 | |
Return on equity | % | 25.3 | 18.9 | 25.1 | 9.0 | 7.1 | |
Return on capital | % | 31.6 | 25.2 | 35.4 | 14.2 | 11.8 | |
Exports to sales | % | 75.4 | 65.2 | 83.9 | 73.1 | 73.3 | |
Imports to sales | % | 33.3 | 26.5 | 20.9 | 38.8 | 47.3 | |
Exports (fob) | Rs m | 353 | 285 | 455 | 372 | 388 | |
Imports (cif) | Rs m | 156 | 116 | 113 | 198 | 250 | |
Fx inflow | Rs m | 353 | 285 | 455 | 372 | 388 | |
Fx outflow | Rs m | 160 | 120 | 114 | 198 | 253 | |
Net fx | Rs m | 193 | 165 | 341 | 174 | 135 |
AURO LAB. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 69 | 93 | 128 | -66 | 33 | |
From Investments | Rs m | -32 | -22 | -35 | -53 | -51 | |
From Financial Activity | Rs m | -18 | -55 | -5 | 98 | -82 | |
Net Cashflow | Rs m | 19 | 16 | 89 | -21 | -100 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sharat Deorah | COMP SEC: Shanu Nag | YEAR OF INC: 1989 | BSE CODE: 530233 | FV (Rs): 10 | DIV YIELD (%): - |
Read: AURO LAB. 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare AURO LAB. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded higher on Tuesday following overnight gain on Wall Street.